Uptake and outcomes of early infant male circumcision services in four counties in Western Kenya.
Adverse event
circumcision
early male infant
uptake
western Kenya
Journal
African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
16
9
2021
Statut:
ppublish
Résumé
Early Infant Male Circumcision (EIMC) is part of sustainable HIV prevention strategies in Kenya. The goals of the national EIMC program are to circumcise at least 40% of all newborn male infants delivered at hospitals offering the service and keep the rate of moderate and adverse events below 2%. To determine the proportion of early male infants (age less than 60 days) born at hospitals in four counties of western Kenya who got circumcised and document the prevalence of adverse events (AEs) among those circumcised. A retrospective descriptive study involving all records for EIMC from 1st March 2014 through 31st March 2018 in four counties of western Kenya. Data analysis was done using EXEL to document proportion of facilities offering EIMC and compare EIMC uptake and outcomes in the four counties against the national goals for the program. A mean of 4.3% of total health facilities offer EIMC in the region. Siaya had the highest proportion of facilities offering EIMC while Migori had the lowest proportion. Uptake of EIMC was low at 17.4% for all male infants born, far less than the anticipated target of 40%. Average adverse event rates were 0.3%. EIMC uptake remains low in this region of Kenya due to small number of health facilities offering the service. The proportion of circumcised early male infants born at the target health facilities is below the national target of 40% even though the rate of adverse events among those circumcised is acceptable.
Sections du résumé
BACKGROUND
BACKGROUND
Early Infant Male Circumcision (EIMC) is part of sustainable HIV prevention strategies in Kenya. The goals of the national EIMC program are to circumcise at least 40% of all newborn male infants delivered at hospitals offering the service and keep the rate of moderate and adverse events below 2%.
OBJECTIVES
OBJECTIVE
To determine the proportion of early male infants (age less than 60 days) born at hospitals in four counties of western Kenya who got circumcised and document the prevalence of adverse events (AEs) among those circumcised.
METHODS
METHODS
A retrospective descriptive study involving all records for EIMC from 1st March 2014 through 31st March 2018 in four counties of western Kenya. Data analysis was done using EXEL to document proportion of facilities offering EIMC and compare EIMC uptake and outcomes in the four counties against the national goals for the program.
RESULTS
RESULTS
A mean of 4.3% of total health facilities offer EIMC in the region. Siaya had the highest proportion of facilities offering EIMC while Migori had the lowest proportion. Uptake of EIMC was low at 17.4% for all male infants born, far less than the anticipated target of 40%. Average adverse event rates were 0.3%.
CONCLUSION
CONCLUSIONS
EIMC uptake remains low in this region of Kenya due to small number of health facilities offering the service. The proportion of circumcised early male infants born at the target health facilities is below the national target of 40% even though the rate of adverse events among those circumcised is acceptable.
Identifiants
pubmed: 34447425
doi: 10.4314/ahs.v21i1.10S
pii: jAFHS.v21.iSupplement.pg59
pmc: PMC8367310
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-63Informations de copyright
© 2021 Andale TO et al.
Références
Reprod Health Matters. 2007 May;15(29):11-4
pubmed: 17512369
Pediatrics. 2012 Jul;130(1):e175-82
pubmed: 22711723
N Engl J Med. 1986 Oct 30;315(18):1167
pubmed: 3762636
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
AIDS Behav. 2010 Oct;14(5):1198-202
pubmed: 19924526
BMC Infect Dis. 2006 Nov 30;6:172
pubmed: 17137513
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
Pediatrics. 1989 Jun;83(6):1011-5
pubmed: 2562792
Int J Epidemiol. 1990 Sep;19(3):693-7
pubmed: 2262266
PLoS One. 2012;7(2):e32475
pubmed: 22384258
Lancet. 1999 Nov 20;354(9192):1813-5
pubmed: 10577659
PLoS Med. 2006 Jan;3(1):e78
pubmed: 16435906
N Y State J Med. 1986 Aug;86(8):446
pubmed: 3463895
Ann Trop Paediatr. 2000 Jun;20(2):101-4
pubmed: 10945058
PLoS Med. 2011 Nov;8(11):e1001130
pubmed: 22140365
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970